Concise --
  • A poster may be the most important scientific work in a decade, but if the presentation is not concise, the judges can not evaluate it properly.
  • The most common mistake is to present too much information, too much data, and too many words. A poster is not a written scientific article. A judge, or a fellow scientist, does not have an hour or two to read a lengthy dissertation.
  • The message should be delivered in large type. Use pictures, bullets, arrows and other devices to deliver the message easily.

Important --
  • Give a short, very clear statement of the importance of your work
  • Examples:
  • This is the first time that this "effect' has been seen
  • This method is ten times faster than the previous method
  • This "effect" shows that consumers are in danger of …
  • This method uses far fewer test animals than…

Relevant --
  • Show relevance to FDA's mission.
  • Don't belabor the relevance, but do show it.
  • If appropriate, show usefulness to industry submissions, to field testing, to standards development, etc.
  • Relevance and importance are closely related, so don't "beat your brains out" trying to decide the difference between the two criteria.

Eye-catching --
  • Yes, the pretty poster often wins.
  • You must attract the judges. A pretty poster does that.
  • Posters don't have to be hi-tech. A simple, clean, attractive poster can accomplish the same mission of getting someone's attention.
  • The most important "eye catcher" is the title. If you can get your "bottom line" across in the title, you're half way toward winning.
  • The second most important "eye catcher" is the conclusion.
  • If I've read the title and the conclusion and I'm still lost, then your poster is in serious trouble, at least from my perspective as a judge.

We developed these guidelines and every month we display a new, understandable poster in the prestigious Commissioner's Conference room.

We have also worked with our fundamental scientists at National Center for Toxicological Research - and they now submit understandable reports weekly - much improved from the techno-babble of years past. Recently, I made a concession to our scientists and call it "clear communication" instead of Plain Language - since they are still disdainful of the term "Plain Language." As a result, I have made progress getting clear communication incorporated into the 2003 FDA Science Forum.

black line image
Previous page Cover Next page